| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 1 | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 1 | |
| | | Single nucleotide variant (missense variant) | succinylcholine response - Toxicity +7 more | GPathogenic; drug response |
| | | Single nucleotide variant (missense variant) | succinylcholine response - Toxicity +7 more | GPathogenic; drug response |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 1 | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 1 | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 1 | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 1 | |
| | | Single nucleotide variant (missense variant) | succinylcholine response - Toxicity +7 more | GPathogenic; drug response |
| | | Single nucleotide variant (missense variant) | not provided +2 more | |
| | | Single nucleotide variant (nonsense) | not provided +1 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 1 +1 more | |
| | | Deletion (frameshift variant) | RYR1-related disorder +1 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 1 | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 1 | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 1 | |
| | | Single nucleotide variant (missense variant) | succinylcholine response - Toxicity +7 more | GPathogenic; drug response |
| | | Single nucleotide variant (missense variant) | desflurane response - Toxicity +7 more | GPathogenic; drug response |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia of anesthesia | |
| | | Single nucleotide variant (intron variant) | RYR1-related disorder +7 more | |
| | | Deletion (frameshift variant) | Malignant hyperthermia, susceptibility to, 1 | |
| | | Single nucleotide variant (missense variant) | Long QT syndrome +7 more | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia of anesthesia | |
| | | Single nucleotide variant (missense variant) | Inborn genetic diseases +4 more | |
| | | Duplication (frameshift variant +1 more) | Central core myopathy +1 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 1 | |
| | | Single nucleotide variant (missense variant) | Central core myopathy | |
| | | Single nucleotide variant (intron variant) | not provided +6 more | GConflicting classifications of pathogenicity |
| | | Deletion (inframe_deletion) | Central core myopathy +2 more | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 1 | |
| | | Single nucleotide variant (missense variant) | succinylcholine response - Toxicity +7 more | GUncertain significance; drug response |
| | | Copy number gain | Specific learning disability | |